Optiscan live with FIVE 1
Thursday, 12 June, 2008
Australian confocal microscopy specialist Optiscan Imaging (ASX: OIL) is expanding the global market for its endomicroscopes, including setting up a US sales office to further awareness of its FIVE 1 endomicroscope for pre-clinical research.
FIVE 1, or fluorescence in vivo endomicroscopy, is aimed at cellular research, including stem cell and tissue regeneration research.
Optiscan also has a partnership with Pentax to develop flexible endomicroscopes, which are being used in a global clinical trial.
Optiscan has set up a sales office in San Diego, California, and has distributors throughout Europe and Asia.
Award-winning system automates vial filling for cell therapy
Celleo's Larkem V40 — created to address one of the bottlenecks holding back cell...
Air pollutant exposure linked to glaucoma, cataracts and suicide
People who are exposed to high levels of air pollution are more likely to develop glaucoma and...
Could this 'nanobone' material allow children to regrow bone?
Australian scientists believe they have found an alternative to invasive bone graft procedures in...
